Latest filing published 12 Oct 2021 for Neurocrine Biosciences INC, €187k.
Filing timeline
BuySaleInsider track record
Dimitri E. Grigoriadis: trading record in brief
Dimitri E. Grigoriadis (senior executive) discloses dealings in Neurocrine Biosciences Inc to SEC (Form 4). We count 126 filings; the first trade dates from 5 February 2008 and the latest from 7 October 2021.
Every open-market trade on record is a sale: 88 sales worth €45.9M. Besides market trades, the filings include 1 share grant and 37 option exercises. In 2021 alone, the filings show no purchases and 6 sales.
On 12 October 2021 came the latest disclosure, an option exercise for €187k in Neurocrine Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dimitri E. Grigoriadis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$43.240.4% of flowCommon StockSEC:0001209191-21-060281:1
- 5,000 shares@ US$104.851.0% of flowCommon StockSEC:0001209191-21-060281:2
- 3,000 shares@ US$104.7501100.0% of flowCommon StockSEC:0001209191-21-060281:0
- 605 shares@ US$113.760.1% of flowCommon StockSEC:0001209191-21-009119:0
- 687 shares@ US$116.670.2% of flowCommon StockSEC:0001209191-21-009119:1
- 803 shares@ US$116.690.2% of flowCommon StockSEC:0001209191-21-009119:2
- 1,218 shares@ US$116.700.3% of flowCommon StockSEC:0001209191-21-009119:3
- 2,257 shares@ US$90.73271.9% of flowCommon StockSEC:0001209191-20-058547:0
- 2,257 shares@ US$118.832.1% of flowCommon StockSEC:0001209191-20-045758:0
- 2,710 shares@ US$32.990.7% of flowCommon StockSEC:0001209191-20-036698:0
- 1,812 shares@ US$35.990.5% of flowCommon StockSEC:0001209191-20-036698:1
- 1,049 shares@ US$43.240.4% of flowCommon StockSEC:0001209191-20-036698:2
- 10,000 shares@ US$125.9810.5% of flowCommon StockSEC:0001209191-20-031028:3
- 32,749 shares@ US$126.7334.5% of flowCommon StockSEC:0001209191-20-031028:4
- 10,000 shares@ US$119.9810.0% of flowCommon StockSEC:0001209191-20-031028:1
- 10,000 shares@ US$35.993.0% of flowCommon StockSEC:0001209191-20-031028:2
- 10,000 shares@ US$35.993.0% of flowCommon StockSEC:0001209191-20-031028:0
- 8,682 shares@ US$105.447.7% of flowCommon StockSEC:0001209191-20-028392:0
- 1,934 shares@ US$99.411.0% of flowCommon StockSEC:0001209191-20-026069:0
- 1,218 shares@ US$103.310.7% of flowCommon StockSEC:0001209191-20-008498:0
- 1,013 shares@ US$103.150.5% of flowCommon StockSEC:0001209191-20-007691:0
- 605 shares@ US$103.150.3% of flowCommon StockSEC:0001209191-20-007691:1
- 803 shares@ US$101.440.4% of flowCommon StockSEC:0001209191-20-007691:2
- 5,000 shares@ US$35.990.8% of flowCommon StockSEC:0001209191-19-057272:0
- 5,000 shares@ US$115.982.5% of flowCommon StockSEC:0001209191-19-057272:1
25 of 119 declarations
